Evan Lipson, MD, an associate professor of oncology at John Hopkins School of Medicine and a head and neck oncologist at John Hopkins Medicine, discusses feedback he’s received from colleagues at Case-Based Roundtable events about patients with melanoma.
Health Professionals
UVA Heath begins new clinical trial to battle deadly melanoma
CHARLOTTESVILLE, Va. (WRIC) — A research team at UVA Health System is pioneering a new approach to treating melanoma, one of the deadliest forms of skin cancer.
Scientists identify key mechanism in development of skin cancer
Melanoma arising from pigment-producing cells known as melanocytes is the deadliest form of skin cancer. A major cause of melanoma is excessive exposure to ultraviolet light, from sunlight or other sources, which can trigger mutations that promote tumor formation.
Blue Eye Color May Be Linked With Greater Uveal Melanoma Risk and Poorer Prognosis
A retrospective study based in the Netherlands found an apparent genetic link between blue eye color and poorer survival in patients with uveal melanoma—including a greater incidence of high-risk tumor development in patients with light eyes than in those with darker eyes—though larger, more diverse studies are needed to confirm these findings.